Carlsmed (CARL) has priced its initial public offering at $15 per share, offering 6.7 million shares and aiming to raise around $100.5 million in gross proceeds, excluding any underwriters’ option.

Now, the unprofitable PomDoctor Ltd. is hoping to join their ranks as China's newest publicly traded online medical services ...

Figma announced Monday it is kicking off its IPO roadshow. The company plans to offer more than 36 million shares of class A ...

Tax software company Avalara, which went private in 2022, disclosed on Monday it had confidentially filed for a U.S. initial ...

Figma founder CEO Dylan Field has disclosed that he plans to sell 2.35 million shares. At the midrange he’ll be cashing out ...

HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

Heartflow's latest IPO filing reveals a significant increase in quarterly losses to $32.3 million while revenue surged to $37.2 million, signaling both challenges and opportunities in the recovering U ...

Healthcare startups are betting that AI can help them do more with less — including in caring for patients.